Boston scientific announces early results of its cash tender offer for its outstanding debt securities and increases aggregate maximum principal amount of its cash tender offer

Marlborough, mass., march 16, 2022 /prnewswire/ -- boston scientific corporation (the "company") (nyse:bsx) today announced that, pursuant to the previously announced cash tender offer (the "tender offer") for up to $2.5 billion aggregate principal amount of the outstanding senior notes identified in the table and the related notes below (the "securities"), $5,139,194,000 in aggregate principal amount of the securities were validly tendered and not validly withdrawn on or prior to 5:00 p.m.
BSX Ratings Summary
BSX Quant Ranking